Lexicon CEO Lonnel Coats to retire effective July 7, 2024; board begins CEO search

LEXICON PHARMACEUTICALS, INC.

Lonnel Coats notified retirement as CEO (principal executive officer) and board member, effective July 7, 2024.
Board of directors has initiated a search for a new CEO, considering both internal and external candidates.
No successor named; Coats continues until effective date.
Lexicon Pharmaceuticals (LXRX) trades on Nasdaq.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lonnel Coats

Chief Executive Officer

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2024-07-07
Filed: April 29, 2024, 7:59 PM ET

On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.

Departed

Lonnel Coats

Member of the Board of Directors

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2024-07-07
Filed: April 29, 2024, 7:59 PM ET

On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Lonnel Coats retired as Chief Executive Officer at LEXICON PHARMACEUTICALS, INC..

Action: retired
Role: Chief Executive Officer

Exact text from the filing

On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Lonnel Coats retired as Member of the Board of Directors at LEXICON PHARMACEUTICALS, INC..

Action: retired
Role: Member of the Board of Directors

Exact text from the filing

On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.

View on SEC.gov

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-24-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.